Bleeding disorder resident survival guide: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 21: | Line 21: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}}; | {{CMG}}; {{AE}} {{JA}} | ||
== Overview == | == Overview == | ||
Line 47: | Line 47: | ||
* Vitamin K Deficiency | * Vitamin K Deficiency | ||
* Drugs such as: | * Drugs such as: | ||
** Warfarin | ** [[Warfarin]] | ||
** Heparin | ** [[Heparin]] | ||
** Hemodilution and massive transfusion | ** Hemodilution and massive transfusion | ||
** Disseminated Intravascular Coagulation (DIC) | ** [[Disseminated Intravascular Coagulation]] (DIC) | ||
** Immunoglobulin mediated Factor Deficiency (VIII, V, XIII, X) | ** Immunoglobulin mediated Factor Deficiency (VIII, V, XIII, X) | ||
** Hyperfibrinolysis | ** [[Hyperfibrinolysis]] | ||
** Venom Induced | ** Venom Induced | ||
==== Prothrombotic: ==== | ==== Prothrombotic: ==== | ||
* Heparin Induced Thrombocytopenia | * [[Heparin Induced Thrombocytopenia]] | ||
* Antiphospholipid Antibody Syndrome | * [[Antiphospholipid Antibody Syndrome]] | ||
* Microvascular Thrombosis (Warfarin Induced Skin Necrosis) | * [[Microvascular Thrombosis]] (Warfarin Induced Skin [[Necrosis]]) | ||
=== Platelet Related Disorders === | === Platelet Related Disorders === | ||
==== Congenital: ==== | ==== Congenital: ==== | ||
* Glanzmann's | * [[Glanzmann's thrombasthenia]] | ||
* Bernard-Soulier | * [[Bernard-Soulier syndrome]] | ||
* Von Willebrand's | * [[Von Willebrand's disease]] | ||
==== Acquired ==== | ==== Acquired ==== | ||
* Myeloproliferative Disorders | * Myeloproliferative Disorders | ||
* Uremia | * [[Uremia]] | ||
* Drugs (NSAIDs, Aspririn, Clopidogrel etc.) | * Drugs (NSAIDs, Aspririn, Clopidogrel etc.) | ||
* Neoplasia | * Neoplasia | ||
* Monoclonal Gammopathies | * Monoclonal Gammopathies | ||
* DIC | * [[DIC]] | ||
* Ehlrichiosis | * [[Ehlrichiosis]] | ||
* Retroviral Infection | * Retroviral Infection | ||
* Snake Venom | * Snake Venom | ||
* Cirrhosis | * [[Cirrhosis]] | ||
== FIRE == | == FIRE == |
Revision as of 21:06, 26 October 2020
Bleeding disorder Resident Survival Guide |
---|
Overview |
Causes |
FIRE |
Diagnosis |
Treatment |
Do's |
Don'ts |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Javaria Anwer M.D.[2]
Overview
Causes
Coagulopathy
The following are the causes of coagulopathy (defects in coagulation):
Genetic:
Hemorrhagic Disorders
- Factor VIII Deficiency
- Factor IX Deficiency
- Von Willebrand Factor Deficiency
- Factor XI Deficiency
- Factor II, V, VII, X Deficiency (Common Pathway Proteins)
- Factor XIII and Fibrinogen Deficiency
Hypercoaguable Diseases
- Antithrombin III Deficiency
- Protein C and S Deficiency
Acquired:
- Prohemorrhagic Liver Diseases
- Vitamin K Deficiency
- Drugs such as:
- Warfarin
- Heparin
- Hemodilution and massive transfusion
- Disseminated Intravascular Coagulation (DIC)
- Immunoglobulin mediated Factor Deficiency (VIII, V, XIII, X)
- Hyperfibrinolysis
- Venom Induced
Prothrombotic:
- Heparin Induced Thrombocytopenia
- Antiphospholipid Antibody Syndrome
- Microvascular Thrombosis (Warfarin Induced Skin Necrosis)
Platelet Related Disorders
Congenital:
Acquired
- Myeloproliferative Disorders
- Uremia
- Drugs (NSAIDs, Aspririn, Clopidogrel etc.)
- Neoplasia
- Monoclonal Gammopathies
- DIC
- Ehlrichiosis
- Retroviral Infection
- Snake Venom
- Cirrhosis
FIRE
A Focused Initial Rapid Evaluation (FIRE) should be performed to identify patients with severe bleeding and in need of immediate intervention.
Boxes in red signify that an urgent management is needed Abbreviations
Boxes in red signify that an urgent management is needed.
Assess the patient for bleeding and screen with CBC, PT, aPTT
❑ Clinical assessment of types and sites of bleeding ❑ Spontaneous or follows trauma ❑ Duration of bleeding (lifelong/recent) ❑ History of blood transfusion ❑ History of bleeding after surgical procedures ❑ Drug History ❑ Family history of bleeding disorders | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Soft tissue hematoma, deep internal hemoorhage, hemarthrosis | Superficial cutaneous or mucous membrane bleeding | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PT Normal, aPTT Prolonged | PT Prolonged, aPTT Normal | PT Prolonged, aPTT Prolonged | Platelet Count Low | Platelet Count Normal | |||||||||||||||||||||||||||||||||||||||||||||||||||||
•Factor VIII, IX, XI Deficiency •Von Willebrand Disease •Heparin Contamination | •Factor VII deficiency •Vitamin K Deficiency | •Check Thrombin Time | •Idiopathic Thrombocytopenic Purpura (ITP) •Hereditary Platelet Disorder •Bone Marrow Failure | •Check PFA-100 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
{{{E01}}} | {{{E02}}} | {{{E03}}} | {{{E04}}} | {{{E05}}} | {{{E06}}} | {{{E07}}} | |||||||||||||||||||||||||||||||||||||||||||||||||||